Liberation Bioindustries Valuation, Funding & Investors

Liberation Bioindustries is valued at $178M as of December 2025.

Last Liberation Bioindustries valuation

$178M

Series A · Dec 2025

Last Liberation Bioindustries funding round

$60M

Series A · Dec 2025

Cumulative funding Liberation Bioindustries raised

$147M

across 7 funding rounds

Key investors in Liberation Bioindustries

  • Agronomics
  • Siddhi Capital
  • CPT Capital
  • New Agrarian
  • 8090 Industries
  • Thia Ventures

Liberation Bioindustries Overview

About Liberation Bioindustries

Liberation Labs is a Chicago-based biotech firm building infrastructure for large-scale precision fermentation of alternative proteins. The company enables innovators to produce animal-free foods at competitive costs, targeting sustainable nutrition markets.


Founded

2021

HQ

United StatesNew York City, NY

Status

Privately held

Customer focus

B2B

Revenue model

Services

Valuation

$178M (Dec 2025)

Liberation Bioindustries Valuation

Liberation Bioindustries is currently valued at $178M, based on its Series A in December 2025.

Liberation Bioindustries valuation by funding round

Liberation Bioindustries valuation by funding round
DateStageValuation
Dec 2025Series A$178M

Liberation Bioindustries Funding History

Liberation Bioindustries has raised a total of $147M across 7 funding rounds.

Liberation Bioindustries' first fundraising round was a $900K seed round in June 2022. The most recent completed round was a $60M Series A in December 2025.

Liberation Bioindustries funding rounds

Liberation Bioindustries funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Dec 2025Series A-$60M$178MLiberation Bioindustries, formerly Liberation Labs, is constructing a 600,000-liter commercial precision-fermentation facility to produce protein and bio-based ingredients for food and industrial manufacturers. The company is in the final stages of building this purpose-built biomanufacturing plant with a fully dedicated downstream process to meet needs of consumer packaged goods companies. Recent partnerships include producing Vivitein™ BLG dairy protein for Vivici announced in May 2025 and a strategic collaboration with Topian, NEOM's food company, in April 2025 to co-develop a fermentation facility in Saudi Arabia. Liberation Bioindustries closed the first tranche of its Series A1 equity round on December 19, 2025, converting convertible loan notes into Series A1 shares. Agronomics converted its notes, increasing its shareholding from 6,834,147 to 16,538,437 shares, with total investment of US$27.0 million now carried at US$46.8 million after a US$2.5 million uplift. New Agrarian Company, an Agronomics affiliate, invested US$2.5 million in the round. Premier Alternatives lists the company's current valuation at $178.0 million as of December 9, 2025, with total funding raised at $132.2 million, including a last Early Stage VC round of $112.2 million in December 2025, and a capital efficiency ratio of 1.35x (valuation/funding). The Series A1 round marks a key milestone post-construction progress on the facility, with Agronomics' position representing about 23% of its net asset value as of September 30, 2025. Later updates include an audited unrealised fair value gain of £1.8 million on Liberation Bioindustries following the round close, as part of Agronomics' NAV calculation at December 31, 2025, and a £4.1 million gain noted in half-year financials.
Jan 2025Undisclosed stageNew Agrarian; Galloway; NEOM Investment Fund; Siddhi Capital; Meach Cove Capital; Agronomics$32M-Liberation Bioindustries (formerly Liberation Labs) is a US-based biotech company commercializing precision fermentation through purpose-built biomanufacturing facilities, including a 600,000-liter commercial-scale plant under construction in Richmond, Indiana, capable of producing 600-1,200 tonnes of protein annually for bio-based ingredients in food, chemicals, and industrial products. The facility, costing around $115M, addresses capacity gaps in US biomanufacturing and is expected to start operations in 2025, bringing in $40M in yearly revenue. On January 30, 2025, the company closed a $50.5M convertible note round, including $31.5M in new capital from investors Agronomics, Galloway Limited, Meach Cove Capital, NEOM Investment Fund, New Agrarian Capital, and Siddhi Capital, plus $19M from 2024 insider bridge notes. This brought total private capital to $71.5M and deployable capital (including public sector awards and loan guarantees) to $125.5M, supplemented by $30M equipment financing and a $25M USDA loan guarantee. Subsequent developments include a Series A1 equity round referenced in late 2025 announcements from Agronomics, which had invested $27M total (carried at $46.8M, ~23% of its NAV as of Sep 2025) and increased its stake to 16,538,437 A1 shares; New Agrarian invested $2.5M. Agronomics previously held a 37.7% stake as of late 2024. The funding supports expansion, including potential facilities in Saudi Arabia backed by NEOM, amid growing demand for secure biotech supply chains.
Oct 2024SeedAgronomics (lead)$2M-Liberation Bioindustries (formerly Liberation Labs) is a US-based precision fermentation company building biomanufacturing facilities for novel protein production. It received a $2 million Secured Promissory Note from Agronomics in October 2024 as part of a $3.39-3.5 million raise, bringing Agronomics' total investment to $19.6 million for a 37.5% fully diluted stake. The funds support construction of its 600,000-liter Launch Facility in Richmond, Indiana, expected operational by Q1 2025, with a $1.39 million DoD grant for a feasibility study on a 4-million-liter expansion. The company has secured letters of intent covering over 200% of the Launch Facility's initial capacity from customers in food, fuel, materials, and pharmaceuticals. Earlier in 2024, it raised $12.5 million including $10 million from Agronomics, with total equity-linked financing at $33.5 million plus $55 million in non-dilutive commitments. By January 2025, it closed a $50.5 million convertible note, reaching $125.5 million total deployable capital including public sector support. In late 2025, Agronomics converted notes in a Series A1 tranche, increasing its investment to $27 million carried at $46.8 million, reflecting strong confidence in the team's execution and the facility's role in US biomanufacturing.
Apr 2024Series AAgronomics (lead); Siddhi Capital$13M--
Dec 2022SeedAgronomics (lead); Siddhi Capital (lead); CPT Capital; 8090 Industries; Thia Ventures; echo$20M--
Oct 2022SeedAgronomics (lead)$20M-Agronomics signed an unconditional agreement to invest up to US$7 million in the US$20 million seed round of Liberation Labs, the precision-fermentation contract manufacturer, co-leading with Siddhi Capital and alongside CPT Capital. An initial US$3.5 million was drawn at first close with the balance callable within 90 days. Following the first tranche Agronomics held 4,700,000 ordinary and 1,067,074 seed preferred shares, a 38.5 per cent fully diluted stake in the company building a 600,000-litre plant at Richmond, Indiana.
Jun 2022SeedAgronomics (lead); New Agrarian; CPT Capital$900K--

Who has invested in Liberation Bioindustries?

10 investors have backed Liberation Bioindustries across its funding rounds, including Agronomics, Siddhi Capital, CPT Capital, New Agrarian, 8090 Industries and Thia Ventures.

Lead investors include Agronomics and Siddhi Capital.


Liberation Bioindustries Investors

Investors in Liberation Bioindustries by funding rounds participated
InvestorHQRoundsRoleFirst check
AgronomicsUnited KingdomDouglas6LeadJun 2022
Siddhi CapitalUnited StatesCherry Hill, NJ3LeadDec 2022
New AgrarianUnited KingdomDouglas2ParticipantJun 2022
CPT CapitalUnited KingdomLondon2ParticipantJun 2022
8090 IndustriesUnited StatesUnited States1ParticipantDec 2022
GallowayUnited KingdomDurham1ParticipantJan 2025
NEOM Investment FundSaudi ArabiaSaudi Arabia1ParticipantJan 2025
Thia VenturesSwitzerlandGeneva1ParticipantDec 2022

This data is available for Pro users. Sign up to see all 10 Liberation Bioindustries investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Liberation Bioindustries Competitors

Liberation Bioindustries competitors include listed companies like Cabio Biotech (Wuhan) Co, Easy Holdings Co and Codexis, and private ones like BlueNalu, Prolific Machines and Jiaozhiwu.

Public and private companies comparable to Liberation Bioindustries
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
BlueNaluUnited StatesSan Diego, CAPrivate--$180M-
Prolific MachinesUnited StatesUnited StatesPrivate--$202M-
Cabio Biotech (Wuhan) CoChinaChinaPublicly listed$84M$33M$211M-
Easy Holdings CoSouth KoreaSouth KoreaPublicly listed$2.5B$163M$217M-
CodexisUnited StatesUnited StatesPublicly listed$70M($36M)$145M2.2x
JiaozhiwuChinaGuangzhouPrivate--$133M-

Liberation Bioindustries Public Comps

Liberation Bioindustries is still privately-owned, but its public comps include Cabio Biotech (Wuhan) Co, Codexis, Easy Holdings Co, Cibus, ArcticZymes, Clover Corp, Novogenia, American Vanguard, Fermentalg and Amoeba.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Cabio Biotech (Wuhan) Co$84M$33M2.2x-5.5x-
Codexis$70M($36M)2.3x2.2x(4.4x)(6.7x)
Easy Holdings Co$2.5B$163M0.5x-7.2x-
Cibus$4M($91M)37.8x28.9x(1.5x)(2.3x)
ArcticZymes$12M$1M7.3x6.4x62.2x44.2x
Clover Corp$61M$9M1.6x1.4x11.0x8.2x
Novogenia$63M$6M0.6x0.6x6.2x(5.2x)
American Vanguard$515M($12M)0.6x0.6x(25.6x)7.8x

This data is available for Pro users. Sign up to see all Liberation Bioindustries competitors and their valuation data.

Start Free Trial

Common questions about Liberation Bioindustries

When was Liberation Bioindustries founded?Liberation Bioindustries was founded in 2021.
Where is Liberation Bioindustries headquartered?Liberation Bioindustries is headquartered in New York City, NY, United States.
Is Liberation Bioindustries publicly listed?No, Liberation Bioindustries is a private, VC-backed company.
What is Liberation Bioindustries' valuation?Liberation Bioindustries was last valued at $178M in its Series A in December 2025.
How much funding has Liberation Bioindustries raised?Liberation Bioindustries has raised $147M across 7 funding rounds.
What was Liberation Bioindustries' last funding round?Liberation Bioindustries' last funding round was a $60M Series A in December 2025.
Who are Liberation Bioindustries' investors?Liberation Bioindustries' investors include Agronomics, Siddhi Capital, New Agrarian, CPT Capital, 8090 Industries, Galloway, NEOM Investment Fund, Thia Ventures, echo and Meach Cove Capital.
Which companies are comparable to Liberation Bioindustries?Companies comparable to Liberation Bioindustries include BlueNalu, Prolific Machines, Cabio Biotech (Wuhan) Co, Easy Holdings Co, Codexis and Jiaozhiwu.

See companies similar to Liberation Bioindustries

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial